AV
Anavex Life Sciences Corp.
AVXL · NASDAQ
$2.62 -3.32% (-$0.09)
1M -18.63%
Market Cap $264.1M
P/E Ratio -
Div. Yield -
ROE 11.96%
Bulios Fair Price
$1.64
37.4% downside
Trenutna cena
$2.62
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica AVXL trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
83 /100
Cheap P/B 2.17x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 12.68%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 14.25%
Asset turnover 0.00x
ROE 11.96%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 18.24x
Int. coverage N/A
Stability
69 /100
Stable Beta 1.14x
Profitable years 0
EPS volatility 8.63%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AVXL
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Terrie Kellmeyer
Employees
34
Headquarters
New York City
Prihajajoči dogodki
24 NOV.
Earnings
Upcoming earnings report